Fig. 1.
Effects of enzalutamide on uterine weights at 8- and 16-week timepoints. (A) Summary of study design. (B) Boxplots of individual uterine:body weight ratios. Circles represent outliers that are >1.5 box-lengths beyond the median. Statistical analysis comparing mean ratios for each treatment group and each timepoint performed by one-way ANOVA with post-hoc Bonferroni testing.